Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;102:1153-1154
doi: 10.1161/CIRCRESAHA.108.177261
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feuerstein, G. Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feuerstein, G. Z.
Related Collections
Right arrowRelated Article
(Circulation Research. 2008;102:1153.)
© 2008 American Heart Association, Inc.


Editorials

Cardiac RAGE in Sepsis

Call TOLL Free for Anti-RAGE

Giora Z. Feuerstein

From Discovery Translational Medicine, Wyeth Research, Collegeville, Pa.

Correspondence to Giora Z. Feuerstein, MD, Discovery Translational Medicine, Wyeth Research, 500 Arcola Rd, S3207, Collegeville, PA 19426. E-mail giorafeuerstein@yahoo.com



See related article, pages 1239–1246


Key Words: sepsis • S1008/9 • RAGE • cardiac failure • Toll-like receptor


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Sepsis is a systemic inflammatory response syndrome triggered by infection. The hallmarks of clinical sepsis are a broad range of systemic and organ function aberrations, including core temperature (hypothermia or hyperthermia), cardiac (rate and contractility), and respiratory and hematologic perturbations. When sepsis results in at least 1 organ failure or dysfunction, it is classified as severe sepsis. Severe sepsis with hypotension unresponsive to fluid resuscitation defines septic shock. Sepsis syndrome afflicts almost 750 000 patients in the United States each year, at a cost of almost $17 billion, and causes more than 200 000 deaths annually. The incidence of sepsis syndrome continues to rise along with the increase in life span and several other important risk factors. Sepsis without organ dysfunction is a relatively benign condition, and spontaneous recovery with conservative measures results in low in-hospital mortality (5% to 10%). Severe sepsis and septic shock carry high mortality, 30% to 50%, in spite of all that modern treatment offers.1–3

Genetic predisposing factors have been proposed including mutations in cytokine genes such as tumor necrosis factor (TNF)-{alpha}, interleukin (IL)-1, and IL-6. Most of these polymorphisms, implicated in increasing severity of sepsis, are associated with increases in these proinflammatory cytokines. Abnormalities in Toll-like receptor-4 and its signaling kinase, IRAK-4, have been associated with worse outcomes. The alarming increase in pathogens resistant to antibiotics that, in the past, were very effective in prevention and treatment of sepsis no doubt contributes to increases in severe sepsis prevalence in the elderly. The key mechanisms . . . [Full Text of this Article]


Related Article:

S100A8 and S100A9 Mediate Endotoxin-Induced Cardiomyocyte Dysfunction via the Receptor for Advanced Glycation End Products
John H. Boyd, Bernard Kan, Haley Roberts, Yingjin Wang, and Keith R. Walley
Circ. Res. 2008 102: 1239-1246. [Abstract] [Full Text] [PDF]